More Confirmation That Elmiron Causes Eye Disease

October 14, 2019 / 11:16 am

Last year researchers stunned the medical community when they claimed that patients taking Elmiron, the brand name of the drug Pentosan, were at much higher risk of eye disease and vision loss. The nationally-recognized team at Colson Hicks Eidson began taking these cases for clients who have been using Elmiron. Now, ophthalmologists have conducted a review of patients in California and found similar results. We are standing by to help those who have been affected by this faulty and dangerous prescription drug.

We are learning more about Elmiron’s harmful effects

Thanks to Dr. Nieraj Jain, a researcher at the Emory Eye Center at the Emory School of Medicine in Atlanta, GA, we discovered a link between Elmiron and eye disease in 2018. Recently, researchers presented even more evidence that Elmiron can cause serious vision problems. They presented their findings at the annual meeting of the American Academy of Ophthalmology in San Francisco.

“This is certainly a mix of good and bad news for patients,” said Alam Hallan, the director of a pharmacy at Guelph General Hospital in Ontario, Canada. “New patients will be monitored more rigorously so this damage can be prevented, but for ones who have already suffered the side effects, this is going to be a difficult situation.

Researchers have found that during the last year, three Kaiser Permanente ophthalmologists in Northern California reviewed medical records of those taking Elmiron. They say that about 25% of those with significant exposure to Elmiron showed noticeable eye damage.

Researchers also noted that the toxicity of the medication could appear as other known retinal conditions, making it harder to pinpoint the eye problems on Elmiron.

How long has Elmiron been in the market?

Elmiron was first approved for use in humans by the US Food and Drug Administration (FDA) in 1995 to treat interstitial cystitis, commonly referred to as “painful bladder syndrome.” Elmiron is the only drug approved to treat this condition, and hundreds of thousands of patients have taken the drug.

Researchers say that a typical drug trial lasts 2 to 5 years and that the retinal damage caused by Elmiron may or may not have been detectable when the drug was undergoing trials in the 1990s.

We can help you through this

If you or a loved one have been taking Elmiron (Pentosan) and think your vision has been affected, please contact the knowledgeable and experienced team at Colson Hicks Eidson today. We are taking this fight directly to Janssen Pharmaceuticals, Inc., the maker of Elmiron. We have vast experience handling nationwide product liability cases and are ready to secure the compensation you deserve. This can include:

  • The cost of your current and future medical bills
  • Recovery of income lost if you are unable to work
  • Pain and suffering damages
  • Mental anguish damages
  • Loss of enjoyment of life damages
  • Punitive damages against a company or manufacturer

When you need an Elmiron eye disease attorney, you can contact us by clicking here or by calling us at 305-476-7442.

Trending Stories

January 22, 2025

Latest Updates
and Insights from Colson

Related News & Case Studies

MIAMI (January 22, 2025) – Colson Hicks Eidson is thrilled to announce that three of its partners have been named in the 2025 Lawdragon 500 Leading Lawyers in America. This impressive guide selects its lawyers through Lawdragon’s independent journalistic research and submissions process.

Now in its 20th year, Lawdragon 500 Leading Lawyers in America recognized Colson Hicks Eidson attorneys Julie Braman Kane, Roberto Martínez, and Curtis Miner for their exceptional work in litigation, plaintiff class action litigation, and white-collar practice areas.

Julie’s work has made a significant difference in the lives of her clients. She has represented plaintiffs in personal injury, commercial, and class action litigation, participating in cases securing hundreds of millions of dollars for clients, including recent resolutions of a data breach class action as well as multiple personal injury and wrongful death matters.

Curtis has tried cases to jury verdicts against auto manufacturers and airlines and has obtained sizable settlements in individual and plaintiffs’ class action litigation, having served as Class Counsel in cases against financial institutions arising out of Ponzi schemes and as part of court-appointed leadership counsel in the Takata Airbags Products Liability Litigation MDL, securing over $1.5 billion in settlements for classes of millions of vehicle owners.

Roberto has secured significant client wins in high-profile cases, including participating in settlements and judgments totaling in excess of $6 billion.

Click here to read the full guide on Lawdragon.

About Colson Hicks Eidson

Colson Hicks Eidson is a renowned law firm based in Miami, Florida, that is recognized as one of the top trial firms in the United States. Built on a foundation of over 50 years of dedication forging strong client relationships, Colson Hicks Eidson handles local, national, and international litigation, with cases spanning from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America, and Europe. Learn more at: www.colson.com.

A federal judge in Florida denied UnitedHealthcare’s motion to dismiss a lawsuit brought by a cancer patient seeking coverage for proton beam radiation therapy to treat his tongue cancer. The patient, Carlos Morera, alleges the insurer wrongfully denied benefits under his healthcare plan, forcing him to pay approximately $195,000 out of pocket for the treatment.

Stephanie A. Casey, a partner at Colson Hicks Eidson, represents Morera and successfully argued that the case should proceed.

“We look forward to presenting the merits of this case at trial. Proton beam radiation therapy has long been recognized as the standard of care for these types of cancers,” she said.

The court’s decision allows Morera to continue his fight to recover treatment costs. Read more about this case on Law360 here.

MIAMI (November 20, 2024) – Colson Hicks Eidson has been named to the 2025 edition of the “Best Law Firms” by Best Lawyers®, recognized at both the national and metropolitan levels. Seven of the firm’s attorneys were also named to the 2025 edition of Best Lawyers® across multiple practice areas.

“We are committed to delivering exceptional representation for our clients. This continued recognition of our firm’s core practice areas highlights the success of our efforts,” said Dean C. Colson, Managing Partner of Colson Hicks Eidson.

Best Lawyers® ranks top lawyers and law firms through a peer review process, using feedback from lawyers, clients, and professional references, along with firm data. Rankings are organized into regional and national tiers.

National Tier 2

● Mass Tort Litigation / Class Actions – Plaintiffs

Metropolitan Tier 1

Miami

● Bet-the-Company Litigation
● Commercial Litigation
● Criminal Defense: White-Collar
● Insurance Law
● Mass Tort Litigation / Class Actions – Plaintiffs
● Medical Malpractice Law – Defendants
● Medical Malpractice Law – Plaintiffs
● Personal Injury Litigation – Plaintiffs
● Product Liability Litigation – Plaintiffs

Metropolitan Tier 2

Miami

● Professional Malpractice Law – Defendants

About Colson Hicks Eidson

Colson Hicks Eidson is a renowned law firm based in Miami, Florida, that is recognized as one of the top trial firms in the United States. Built on a foundation of over 50 years of dedication forging strong client relationships, Colson Hicks Eidson handles local, national, and international litigation, with cases spanning from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America, and Europe. Learn more at: www.colson.com.

MIAMI (November 12, 2024) – Colson Hicks Eidson announced today that managing partner Dean Colson has been recognized in Florida Trend’s 2024 edition of the Florida 500, a publication highlighting the 500 most influential executives across various economic sectors in the state.

The publication notes that Dean’s credentials include chairing the state university system’s Board of Governors, the board of trustees for Florida International University, and the board of trustees for the University of Miami.

Dean is renowned as a top trial lawyer in the U.S. with 40 years of experience in complex civil litigation, personal injury, product liability, and professional malpractice. He has successfully represented large plaintiff classes and handled multimillion-dollar cases, including high-profile litigation such as the AeroPeru airplane crash and a Ponzi scheme settlement.

Dean has demonstrated a strong commitment to community service through various leadership roles. He has been actively involved with the Institute of Contemporary Art in Miami, supporting access to the arts. He’s also been president of the Orange Bowl Committee and chaired the Super Bowl XXIX Host Committee. He served on the Florida Commission on Ethics and chaired the Florida Supreme Court Judicial Nominating Commission. He previously served as President of the Dade County Bar Association and as a distinguished member of the Florida Bar Board of Governors. Most recently, the Coral Gables Community Foundation recognized Dean at its 2024 Annual Gala with the Education Award.

About Colson Hicks Eidson

Colson Hicks Eidson is a renowned law firm based in Miami, Florida, that is recognized as one of the top trial firms in the United States. Built on a foundation of over 50 years of dedication to forging strong client relationships, Colson Hicks Eidson handles local, national, and international litigation, with cases spanning from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America, and Europe. Learn more at: www.colson.com.

The U.S. Attorney’s Office for the Southern District of Florida has launched a new Whistleblower Non-Prosecution Pilot Program. It reinforces the recent efforts of the Department of Justice Criminal Division’s new Corporate Whistleblower Awards Pilot Program.

The local pilot program offers non-prosecution agreements in exchange for the early and voluntary self-disclosures of criminal conduct.  The Department’s pilot program offers financial rewards to a whistleblower who provides original and truthful information about corporate misconduct that results in a successful forfeiture.  

Both pilot programs require the prompt disclosure of truthful and complete information.   

At Colson Hicks Eidson, our attorneys have advised and represented clients across the full range of internal investigations, government inquiries, enforcement actions, whistleblower actions, and civil and criminal trials.  For further information, contact us at 305-476-7400 or info@colson.com.

MIAMI (June 24, 2024) – Colson Hicks Eidson announced today that six of its attorneys have been named in the 2024 edition of Florida Super Lawyers. Stephanie Casey, Dean Colson, Joseph J. Kalbac, Jr., Julie Braman Kane, and Curtis Miner have been named Super Lawyers. Zachary Lipshultz has been recognized as a Rising Star.

Super Lawyers uses a rigorous screening process including independent research, peer nominations, and evaluations to rate lawyers. Only 5 percent of lawyers in Florida are rated by Super Lawyers, and no more than 2.5 percent of lawyers under 40 or with fewer than 10 years of practice are selected as Rising Stars.

About Colson Hicks Eidson

Colson Hicks Eidson is a renowned law firm based in Miami, Florida, that is recognized as one of the top trial firms in the United States. Built on a foundation of over 50 years of dedication forging strong client relationships, Colson Hicks Eidson handles local, national, and international litigation, with cases spanning from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America, and Europe. Learn more at: www.colson.com.